Business

Mass. Movers

Post-acquisition, Cynosure loses $1.3m

Cynosure, which makes laser-and light-based aesthetic treatment systems, unveiled a $25 million stock buyback.

Cynosure, which makes laser-and light-based aesthetic treatment systems, unveiled a $25 million stock buyback.

Advertisement

Cynosure Inc. reported a net loss of $1.3 million, or 6 cents per share, including acquisition costs for Palomar, which it purchased in June. Excluding those costs, earnings per share were 23 cents. Revenue of $60.7 million, while up 64 percent, fell short of the consensus estimate of $61.6 million. It was the first full quarter for the combined company. CEO Michael Davin said the acquisition remains on track to achieve $8 million to $10 million in cost synergies.

Loading comments...
Real journalists. Real journalism. Subscribe to The Boston Globe today.
We hope you've enjoyed your free articles.
Continue reading by subscribing to Globe.com for just 99¢.
 Already a member? Log in Home
Subscriber Log In

We hope you've enjoyed your 5 free articles'

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com